DE69727811D1 - Verwendung einer glukosehaltigen lösung in der peritonealdialyse mit verminderter bildung von zersetzungsprodukten - Google Patents

Verwendung einer glukosehaltigen lösung in der peritonealdialyse mit verminderter bildung von zersetzungsprodukten

Info

Publication number
DE69727811D1
DE69727811D1 DE69727811T DE69727811T DE69727811D1 DE 69727811 D1 DE69727811 D1 DE 69727811D1 DE 69727811 T DE69727811 T DE 69727811T DE 69727811 T DE69727811 T DE 69727811T DE 69727811 D1 DE69727811 D1 DE 69727811D1
Authority
DE
Germany
Prior art keywords
glucose
peritoneal dialysis
reduced formation
containing solution
decomposition products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69727811T
Other languages
English (en)
Other versions
DE69727811T2 (de
Inventor
Anders Wieslander
Anne Dawney
Reinhold Deppisch
Thomas Henle
Gunita Forsbaeck
Torbjoern Linden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gambro Lundia AB
Original Assignee
Gambro Lundia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20401466&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69727811(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gambro Lundia AB filed Critical Gambro Lundia AB
Publication of DE69727811D1 publication Critical patent/DE69727811D1/de
Application granted granted Critical
Publication of DE69727811T2 publication Critical patent/DE69727811T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
DE69727811T 1996-02-20 1997-02-19 Verwendung einer glukosehaltigen lösung in der peritonealdialyse mit verminderter bildung von zersetzungsprodukten Expired - Lifetime DE69727811T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9600631A SE9600631D0 (sv) 1996-02-20 1996-02-20 Use of a solution comprising glucose for peritonial dialysis having reduced formation of AGE products
SE9600631 1996-02-20
PCT/SE1997/000272 WO1997030694A1 (en) 1996-02-20 1997-02-19 Use of a solution comprising glucose for peritoneal dialysis having reduced formation of age products

Publications (2)

Publication Number Publication Date
DE69727811D1 true DE69727811D1 (de) 2004-04-01
DE69727811T2 DE69727811T2 (de) 2004-08-05

Family

ID=20401466

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69727811T Expired - Lifetime DE69727811T2 (de) 1996-02-20 1997-02-19 Verwendung einer glukosehaltigen lösung in der peritonealdialyse mit verminderter bildung von zersetzungsprodukten

Country Status (8)

Country Link
US (1) US6241943B1 (de)
EP (1) EP0914093B1 (de)
JP (1) JP2000504745A (de)
AT (1) ATE260091T1 (de)
DE (1) DE69727811T2 (de)
ES (1) ES2212075T3 (de)
SE (1) SE9600631D0 (de)
WO (1) WO1997030694A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE521219C2 (sv) * 1998-10-23 2003-10-14 Gambro Ab Metod och anordning för att reducera nedbrytning av värmekänsliga komponenter i medicinska substanser under värmesterilisering
US6770148B1 (en) * 1998-12-04 2004-08-03 Baxter International Inc. Peritoneal dialysis solution containing modified icodextrins
US7186420B2 (en) 1999-04-26 2007-03-06 Edwards Lifesciences Corporation Multi-part substitution infusion fluids and matching anticoagulants
DE60039978D1 (de) 1999-04-26 2008-10-02 Edwards Lifesciences Ag Substitutions-infusionflüssigkeit und zitratanticoagulation
US8105258B2 (en) 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
DE19955578C1 (de) * 1999-11-18 2001-09-06 Fresenius Medical Care De Gmbh Mehrkammerbehälter, mit Glucosekonzentratkompartiment und Salzsäurekonzentratkompartiment
JP2002145782A (ja) * 2000-11-02 2002-05-22 Shimizu Pharmaceutical Co Ltd ブドウ糖含有製剤およびその製造方法
US20040121982A1 (en) * 2002-12-20 2004-06-24 Leo Martis Biocompatible dialysis fluids containing icodextrins
US20040229771A1 (en) * 2003-05-15 2004-11-18 Reinhold Deppisch Method of reducing decline of or preserving residual renal function
US7053059B2 (en) * 2003-07-25 2006-05-30 Baxter International Inc. Dialysis solutions with reduced levels of glucose degradation products
US20050276868A1 (en) * 2004-06-10 2005-12-15 Bart Degreve Bicarbonate-based peritoneal dialysis solutions
US7935070B2 (en) * 2005-01-28 2011-05-03 Fresenius Medical Care North America Systems and methods for dextrose containing peritoneal dialysis (PD) solutions with neutral pH and reduced glucose degradation product
US20090214807A1 (en) 2008-02-27 2009-08-27 Shawn Davis Peelable seals including porous inserts
US9585810B2 (en) 2010-10-14 2017-03-07 Fresenius Medical Care Holdings, Inc. Systems and methods for delivery of peritoneal dialysis (PD) solutions with integrated inter-chamber diffuser
CN103619372A (zh) 2011-03-23 2014-03-05 纳科斯达格医药股份有限公司 腹膜透析系统、装置和方法
US9861733B2 (en) 2012-03-23 2018-01-09 Nxstage Medical Inc. Peritoneal dialysis systems, devices, and methods
DE102012007165B4 (de) 2012-04-07 2017-06-14 Manfred Völker Saures Dialysekonzentrat
US11207454B2 (en) 2018-02-28 2021-12-28 Nxstage Medical, Inc. Fluid preparation and treatment devices methods and systems

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643201A (en) * 1984-07-09 1997-07-01 Peabody; Alan M. Continuous peritoneal dialysis apparatus
AU658845B2 (en) * 1990-08-20 1995-05-04 Abbott Laboratories Medical drug formulation and delivery system
SE9103395D0 (sv) * 1991-11-18 1991-11-18 Gambro Ab System med anvaendning av ensteril medicinsk loesning innehaallande glukos eller glukosliknande aemnen samt en loesning avsedd foer detta system

Also Published As

Publication number Publication date
EP0914093B1 (de) 2004-02-25
SE9600631D0 (sv) 1996-02-20
JP2000504745A (ja) 2000-04-18
WO1997030694A1 (en) 1997-08-28
EP0914093A1 (de) 1999-05-12
ES2212075T3 (es) 2004-07-16
DE69727811T2 (de) 2004-08-05
US6241943B1 (en) 2001-06-05
ATE260091T1 (de) 2004-03-15

Similar Documents

Publication Publication Date Title
DE69727811D1 (de) Verwendung einer glukosehaltigen lösung in der peritonealdialyse mit verminderter bildung von zersetzungsprodukten
NO875299L (no) Insulinpreparat for ikke-paranteral administrasjon.
TNSN00206A1 (en) Method for treating diabetes
EP1008341A4 (de) Glukose enthaltende zubereitung
AU6256196A (en) Method for noninvasive intermittent and/or continuous hemogl obin, arterial oxygen content, and hematocrit determination
IE790952L (en) Acyl-carnitine solutions for haemodialysis
AU2161888A (en) Anti-acne composition
PT88029A (pt) Processo para a preparacao de derivados piperazinilo de purinas e seus isoesteres uteis como agentes hipoglicemicos
DE19748290B8 (de) Lösung für die Peritonealdialyse
WO2001032157A3 (en) Pharmaceutical composition comprising a combination of metformin and glibenclamide
FI971951A0 (fi) 2,2-dikloroalkaanikarboksyylihapot, menetelmät niiden valmistamiseksi, niitä sisältävät lääkkeet, ja niiden käyttö insuliiniresistanssin hoitoon
ES8606407A1 (es) Un procedimiento para preparar conjugados de galactosil-insulina
EP0214017A3 (en) Use of n,n,-dimethylbiguanid p-chorophenoxyacetate in the treatment of neuropathies and nerval degeneration
NZ336319A (en) Pharmaceutical composition for non-colloidal iron (ferric) delivery in hemodialysis and peritoneal dialysis patients
ATE22655T1 (de) Infusionsloesungen zur herztherapie.
DE69809587T2 (de) Konzentrat für medizinische lösung und dessen verwendung
AU6950287A (en) Zero insertion force socket for photoactivation patient treatment system
NO20002008L (no) Løsning for peritonealdialyse og fremgangsmÕte for fremstilling derav
KR940008678A (ko) 주사용 메스나 액제
DE69600367D1 (de) Verwendung von Sulfasalazin und/oder dessen aktiven Metaboliten zur Herstellung eines Arzneimittels zur Behandlung von venöser Insuffizienz und venösen Ulcera
DE59006292D1 (de) Wässrige Lösungen von Natriumsalzen des Trimercapto-s-triazins, deren Herstellung und Verwendung.
ATE82269T1 (de) Verfahren zur herstellung von 1-pyrazolinen.
DE69529070T2 (de) Verwendung von 5,6-o-benzyliden-l-ascorbinsäure oder deren salze zur herstellung eines medikaments zur behandlung von hiv
AU5199286A (en) New use of 1,4-dihydropyridine derivatives
DE3687448T2 (de) Verwendung von 6h-7,8-dihydrothiapyrano(3,2d)pyrimidinen zur herstellung von arzneimitteln zur verwendung als hypoglykaemische mittel oder als abmagerungsmittel fuer fettsuechtige patienten.